Meeting program compliance requirements and pushing back on escalating manufacturer restrictions are the top concerns of pharmacy leaders, as uncovered during the August 2022 Cloudmed 340B Insider interactive webinar. A full 72% of respondents cited one or the other as their primary program concern, with revenue loss largely resulting from discount restrictions ranked third.
Download the full summary report for more information on:
- Additional industry insights
- Regulatory updates from the experts
- Advice on how to offset savings loss
- What to know about compliance and HRSA audits
- FAQs answered by an expert panel